Autoimmune hepatitis induced by pegylated interferon in an HIV-infected patient with chronic hepatitis C

Journal of Antimicrobial Chemotherapy

Volumn 62, Issue 6, 2008, Pages 1470-1472

  Vispo, Eugenia ^a   Maida, Ivana ^a   Moreno, Alberto ^b   Barreiro, Pablo ^a   Soriano, Vincent ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Autoimmunity; Liver biopsy; Liver fibrosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIRETROVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; ATAZANAVIR; EMTRICITABINE; PEGINTERFERON ALPHA2B; PREDNISONE; RIBAVIRIN; RITONAVIR; TENOFOVIR; VIRUS RNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANAMNESIS; ANTIBODY TITER; ARTHRALGIA; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASTHENIA; AUTOIMMUNE HEPATITIS; CASE REPORT; CHOLESTASIS; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DRUG RESPONSE; ECHOGRAPHY; FEMALE; FEVER; GENOTYPE; HEPATITIS C; HEPATOSPLENOMEGALY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LIVER BIOPSY; LIVER FIBROSIS; MYALGIA; TREATMENT DURATION; VIRUS DETECTION;

FEMALE; HEPATITIS C, CHRONIC; HEPATITIS, AUTOIMMUNE; HIV INFECTIONS; HUMANS; INTERFERON ALFA-2B;

EID: 56649091419     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn416     Document Type: Letter

References (16)

1. Boberg K, Aadland E, Jahnsen J et al. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 1998; 33: 99-103.
2. Puius Y, Dove L, Brust D et al. Three cases of autoimmune hepatitis in HIV-infected patients. J Clin Gastroenterol 2008; 42: 425-9.
3. German V, Vassiloyanakopoulos A, Sampaziotis D et al. Autoimmune hepatitis in an HIV infected patient that responded to antiretroviral therapy. Scand J Infect Dis 2005; 37: 148-51.
4. Ramadori G, Lohr H, Rossol S et al. Human immunodeficiency virus infection mimics autoimmune hepatitis - a case report. Klin Wochenschr 1988; 66: 1040.
5. Alvarez F, Berg P, Bianchi F et al. International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-38.
6. Lohse A, Hennes E. Diagnostic criteria for autoimmune hepatitis. Hepatol Res 2007; 37 Suppl 3: S509.
7. Clifford B, Donahue D, Smith L et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995; 21: 613-9.
8. Conrad B. Potential mechanisms of interferon-alpha induced autoimmunity. Autoimmunity 2003; 36: 519-23.
9. Papo T, Marcellin P, Bernuau J et al. Autoimmune chronic hepatitis exacerbated by alpha-interferon. Ann Intern Med 1992; 116: 51-3.
10. Steegmann J, Requena M, Martin-Regueira P et al. High incidence of autoimmune alterations in chronic myeloid leukemia patients treated with interferon-alpha. Am J Hematol 2003; 72: 170-6.
11. Krause I, Valesini G, Scrivo R et al. Autoimmune aspects of cytokine and anticytokine therapies. Am J Med 2003; 115: 390-7.
12. Youngster S, Wang Y, Grace M et al. Structure, biology, and therapeutic implications of pegylated interferon alpha-2b. Curr Pharm Des 2002; 8: 2139-57.
13. Cazanave C, Rakotondravelo S, Morlat P et al. Autoimmune hepatitis in a HIV-HCV co-infected patient: Diagnostic and therapeutic difficulties. Rev Med Interne 2006; 27: 414-9.
14. Coriat R, Podevin P. Fulminant autoimmune hepatitis after successful interferon treatment in an HIV-HCV co-infected patient. Int STD AIDS 2008; 19: 208-10.
15. O'Leary JG, Zachary K, Misdraji J et al. De novo autoimmune hepatitis during immune reconstitution in an HIV-infected patient receiving highly active antiretroviral therapy. Clin Infect Dis 2008; 46: E12-4.
16. Kanzler S, Gerken G, Lohr H et al. Duration of immunosuppressive therapy in autoimmune hepatitis. J Hepatol 2001; 34: 354-5.